OPTIMIZERX CORP
OPTIMIZERX CORP
Aktie · US68401U2042 · OPRX (XNAS)
Übersicht Finanzkennzahlen
14,61 USD
2,53 % 0,36 USD
NASDAQ (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
06.06.2025 20:35

Aktuelle Kurse von OPTIMIZERX CORP

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
OPRX
USD
06.06.2025 20:35
14,61 USD
14,17 USD
+3,11 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % 18,30 % 47,43 % 219,00 % 172,57 % 31,38 % 13,70 %

Firmenprofil zu OPTIMIZERX CORP Aktie

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

Unternehmensdaten

Name OPTIMIZERX CORP
Firma OptimizeRx Corporation
Symbol OPRX
Website https://www.optimizerx.com
Heimatbörse XNAS NASDAQ
ISIN US68401U2042
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Healthcare Information Services
CEO Mr. Stephen L. Silvestro
Marktkapitalisierung 156 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,1 T
Adresse 400 Water Street, 48307 Rochester
IPO Datum 2007-11-28

Aktien-Splits

Datum Split
14.05.2018 1:3
02.04.2008 1:1000

Ticker Symbole

Name Symbol
NASDAQ OPRX

Weitere Aktien

Investoren die OPTIMIZERX CORP die halten, haben auch folgende Aktien im Depot:
AMGEN INC
AMGEN INC Aktie
AUTODESK INC
AUTODESK INC Aktie
BIOGEN INC
BIOGEN INC Aktie
BRAZIL 24/54
BRAZIL 24/54 Anleihe
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Aktie
EBAY INC
EBAY INC Aktie
INTEL CORP
INTEL CORP Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
NET ELEMENT INC
NET ELEMENT INC Aktie
O'REILLY AUTOMOTIVE INC
O'REILLY AUTOMOTIVE INC Aktie
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Aktie
WERTGRUND WELECT D
WERTGRUND WELECT D Fonds
YANGO JU.IN. 21/22
YANGO JU.IN. 21/22 Anleihe
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025